overview
The VICTOR2™ D fluorometer is designed for all PerkinElmer diagnostic and screening assays based on either time-resolved fluorescence or prompt fluorescence. VICTOR2 D includes MultiCalc software for assay evaluation and quality control.
The VICTOR2™ D platform has been used in over 200 NBS laboratories all over the world. The large number of users is a testament to the quality and reliability of the platform: nearly 10 million newborns are screened with with the VICTOR2™ D platform each year. The semi-automated system is a robust, cost-efficient solution for screening of Prenatal and sevenNBS disorders: congenital hypothyroidism, phenylketonuria, congenital adrenal hyperplasia, galactosemia, cystic fibrosis, biotinidase deficiency and G6PD deficiency.
PerkinElmer maternal serum biochemistry assays are based on the robust and sensitive DELFIA® chemistry with measurement by time-resolved fluorometry.
The VICTOR2™ D platform has been used in over 200 NBS laboratories all over the world. The large number of users is a testament to the quality and reliability of the platform: nearly 10 million newborns are screened with with the VICTOR2™ D platform each year. The semi-automated system is a robust, cost-efficient solution for screening of Prenatal and sevenNBS disorders: congenital hypothyroidism, phenylketonuria, congenital adrenal hyperplasia, galactosemia, cystic fibrosis, biotinidase deficiency and G6PD deficiency.
PerkinElmer maternal serum biochemistry assays are based on the robust and sensitive DELFIA® chemistry with measurement by time-resolved fluorometry.
- Assays optimized for prenatal risk assessment and newborn screening
- All screening assays are CE-IVD marked, aneuploidy screening
- Assays under Annex 2, List B (Medium risk products)
- Extensive internal QC
- Low lot-to-lot variation